Wealth Enhancement Advisory Services, LLC Regeneron Pharmaceuticals, Inc. Transaction History
Wealth Enhancement Advisory Services, LLC
- $46.2 Billion
- Q4 2024
A detailed history of Wealth Enhancement Advisory Services, LLC transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Wealth Enhancement Advisory Services, LLC holds 30,914 shares of REGN stock, worth $21.6 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
30,914
Previous 30,994
0.26%
Holding current value
$21.6 Million
Previous $32.6 Million
32.42%
% of portfolio
0.05%
Previous 0.07%
Shares
12 transactions
Others Institutions Holding REGN
# of Institutions
1,493Shares Held
85.8MCall Options Held
1.53MPut Options Held
1.44M-
Vanguard Group Inc Valley Forge, PA9.29MShares$6.49 Billion0.12% of portfolio
-
Black Rock Inc. New York, NY8.45MShares$5.9 Billion0.2% of portfolio
-
Jpmorgan Chase & CO New York, NY7.06MShares$4.93 Billion0.41% of portfolio
-
State Street Corp Boston, MA4.83MShares$3.38 Billion0.14% of portfolio
-
Capital International Investors Los Angeles, CA4.74MShares$3.31 Billion0.66% of portfolio
About REGENERON PHARMACEUTICALS, INC.
- Ticker REGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 107,190,000
- Market Cap $74.9B
- Description
- Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...